Tak Paul Peter's Form 4 filing
Candel Therapeutics, Inc. (CADL) · filed Sep 11, 2026
- Accession no.
- 0001873905-26-000002
- Filed
- Sep 11, 2026, 6:12 PM ET
- Trade date
- Sep 10-11, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.16M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tak Paul PeterCIK 0001873905 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | Common Stock | MOption exerciseAcquired | +125,000 | $1.55 | +$193,750 | 393,566 | Direct | |
| Sep 10, 2026 | Common Stock | SSaleDisposed | −220,866 | $11.50 | −$2,539,892.74 | 172,700 | Direct | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −59,379 | $10.46 | −$620,890.58 | 113,321 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | Common Stock | MOption exerciseDisposed | −125,000 | $0.00 | $0 | 1,638,968 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.